---
title: "GOVX.US (GOVX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/GOVX.US/news.md"
symbol: "GOVX.US"
name: "GOVX.US"
parent: "https://longbridge.com/en/quote/GOVX.US.md"
datetime: "2026-03-18T11:41:57.962Z"
locales:
  - [en](https://longbridge.com/en/quote/GOVX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/GOVX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/GOVX.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/GOVX.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/GOVX.US/news.md)


# GOVX.US (GOVX.US) — Related News

### [12 Health Care Stocks Moving In Friday's Intraday Session](https://longbridge.com/en/news/275930262.md)
*2026-02-13T17:05:42.000Z*
> In Friday's trading session, several health care stocks experienced significant movements. American Well (AMWL) surged 3

### [Geovax Labs Inc trading halted, news pending](https://longbridge.com/en/news/272145180.md)
*2026-01-10T07:08:48.000Z*
> Geovax Labs Inc trading halted, news pending

### [GeoVax Labs Signs Multiple Material Agreements](https://longbridge.com/en/news/270536080.md)
*2025-12-22T21:43:00.000Z*
> GeoVax Labs announced agreements for a public offering of 13,244,896 common units, raising approximately $2.9 million. T

### [GeoVax Receives Formal EMA Scientific Advice Supporting Pivotal Phase 3 Immunobridging Trial for GEO-MVA](https://longbridge.com/en/news/270173602.md)
*2025-12-18T14:04:21.000Z*
> GeoVax Labs, Inc. announced receiving formal Scientific Advice from the European Medicines Agency (EMA) for its Phase 3 

### [GeoVax Labs: Vaccine Progress Amid Financial Challenges](https://longbridge.com/en/news/266045923.md)
*2025-11-16T00:03:19.000Z*
> GeoVax Labs, Inc. reported mixed results in its Q3 earnings call. The company is advancing its GEO-MVA vaccine, receivin

### [Roth MKM Remains a Buy on GeoVax Labs (GOVX)](https://longbridge.com/en/news/265946426.md)
*2025-11-14T13:57:07.000Z*
> Roth MKM's Jonathan Aschoff maintains a Buy rating on GeoVax Labs with a $14.00 price target. Aschoff, who covers the He

### [GeoVax Labs Reports Q3 2025 Financial Results](https://longbridge.com/en/news/265840913.md)
*2025-11-14T04:03:39.000Z*
> GeoVax Labs Reports Q3 2025 Financial Results

### [GeoVax Labs | 8-K: FY2025 Q3 Revenue Meets Estimate at USD 0](https://longbridge.com/en/news/265801470.md)
*2025-11-13T22:27:00.000Z*